Cardiovascular Medicine
Showing page 5 of 17 pages of list content
-
QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin
This article's authors -
ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study
This article's authors -
A Nationwide Survey of UK cardiac surgeons’ view on clinical decision making during the COVID-19 pandemic
This article's authors -
Experience with Hydroxychloroquine and Azithromycin in the COVID-19 Pandemic: Implications for QT Interval Monitoring
This article's authors -
Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection
This article's authors -
Survival After In-Hospital Cardiac Arrest In Critically Ill Patients Implications For The Covid-19 Pandemic?
This article's authors -
Myocyte Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2 mediated myocarditis
This article's authors -
The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin
This article's authors -
Clinical features and outcomes of 2019 novel coronavirus-infected patients with high plasma BNP levels
This article's authors -
Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study
This article's authors